RE:KalapaWith this (“potentially”) new 25% stake in Kalapa, plus the option to purchase the remaining 75% of the company (AT THE SAME SHARE PRICE of $1.40) prior to the end of this year would be a great idea in my opinion.
Kalapa currently holds 6 subsidiary companies which include:
1.
Kalapa Clinic https://www.kalapa-clinic.com/ The main entity I believe... They specialize in clinical treatments using cannabinoids
2.
KSK Labs https://ksklabs.com/ KSK Labs commercializes a brand of CBD rich products that consist mainly of oils in different concentrations, creams, and CBD rich teas of various compositions.
3.
myCBD https://www.mycbd.com/ Sells KSK Labs products under the name myCBD.
4.
CBM Labs https://cbm-labs.com/ Uses a unique and innovative knowledge in discovering and developing new breakthroughs in the field of cannabinoid based medicines that will drastically eliviate the discomfort for patient groups that are suffering from a variety of medical conditions ranging from insomia to cancer. 5.
CBDinol https://www.cbdinol.com/ CBDinol was founded in 2016, due to the sheer lack of high-quality CBD oils available across Europe. They are committed to providing their consumers with the highest quality hemp oil available on the market and are more than happy to prove this with their analysis results, which are updated with every new batch. 6.
CanPharma https://canpharma.de/ CanPharma will supply German pharmacies with both dried cannabis and cannabis extracts. CanPharma has also applied
for an import and distribution license in Germany. Tons of potential here, and it is making me excited!
Happy Investing!